Raghuveer Mali

Genentech, Inc - South San Francisco / United States

Medical and Health Sciences / Medical Oncology

AD Scientific Index ID: 4380936

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Raghuveer Mali's MOST POPULAR ARTICLES

1-) Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesisZ Cai, JJ Kotzin, B Ramdas, S Chen, S Nelanuthala, LR Palam, R Pandey, ...Cell stem cell 23 (6), 833-849. e5, 20181892018

2-) Therapeutic potential of targeting the oncogenic SHP2 phosphataseLF Zeng, RY Zhang, ZH Yu, S Li, L Wu, AM Gunawan, BS Lane, RS Mali, ...Journal of medicinal chemistry 57 (15), 6594-6609, 20141162014

3-) Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic MastocytosisF Traina, V Visconte, AM Jankowska, H Makishima, CL O’Keefe, P Elson, ...Public Library of Science 7 (8), e43090, 20121162012

4-) Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia modelsRS Mali, Q Zhang, RA DeFilippis, A Cavazos, VM Kuruvilla, J Raman, ...Haematologica 106 (4), 1034, 20201122020

5-) Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRS Mali, B Ramdas, P Ma, J Shi, V Munugalavadla, E Sims, L Wei, ...Cancer cell 20 (3), 357-369, 20111032011

ARTICLES

Add your articles